Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
- Author:
Jongmoo PARK
1
;
Jae Won PARK
;
Min Kyu KANG
Author Information
- Publication Type:Review
- Keywords: Hepatocellular carcinoma; Image-guided radiotherapy; Radiotherapy; Stereotactic body radiotherapy
- MeSH: Carcinoma, Hepatocellular; Catheter Ablation; Decision Making; Radiosurgery; Radiotherapy; Radiotherapy, Image-Guided
- From:Yeungnam University Journal of Medicine 2019;36(3):192-200
- CountryRepublic of Korea
- Language:English
- Abstract: Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.
